Indole-3-Propionic acid, A Gut Microbiota Metabolite, Protects Against the Development of Postoperative Delirium

• Published in: Annals of surgery
• Main Authors: Zhou, Xue, Wu, Xinbo, Wu, Yan, Yang, Liuyue, Shi, Eleanor, Ding, Weihua, Chen, Liang, Shi, Xu, Feng, Xia, Su, Chienwen, You, Zerong, Xia, Jianguo, Chen, Cynthia, Yeliseyev, Vladimir, Bry, Lynn, Xia, Suyun, Huang, Peigen, Meng, Jiawei, Houle, Timothy, Akeju, Oluwaseun, Mao, Jianren, Gerszten, Robert, Chen, Qian, Xie, Zhongcong, Shen, Shiqian
• Format: Journal Article
• Language: English
• Published: United States 01.12.2023
• ISSN: 1528-1140
• DOI: 10.1097/SLA.0000000000005886

Determine preoperative gut microbiota metabolites that may be associated with postoperative delirium (POD) development in patients and further study in rodents. POD occurs in 9-50% of older patients undergoing anesthesia/surgery but lacks effective treatments or prevention. High throughput metabolomics using liquid chromatography with tandem mass spectrometry have accelerated disease-related biomarkers discovery. We performed metabolomic studies in humans to identify potential metabolite biomarkers linked to POD and examined potential mechanisms in rodents. We performed a prospective observational cohort study to examine the metabolomic changes that were associated with the development of POD. Then the gut microbiota-related metabolomic changes were recapitulated by gut microbiota perturbation in rodents. POD was assessed in mice using a battery of behavioral tests including novel objective test, Y maze test, open field test, and buried food test. The mechanisms through which gut microbiota-related metabolomic changes influenced POD were examined using chemogenetics. IPA is a gut microbiota metabolite that belongs to the indole family. Baseline plasma levels of IPA were significantly inversely correlated with the onset of POD in 103 (17 cases) human individuals. This relationship was validated in preclinical mouse models for POD: reducing IPA levels through gut microbiota perturbation promoted POD-like behavior. More importantly, IPA administration deterred POD-like behavior. Colonization of germ-free mice with mutant Clostridium sporogenes that did not produce IPA promoted POD-like behavior. Chemogenetic studies revealed that the protective effect of IPA in mice was mediated, in part, by peroxisome proliferator-activated receptor gamma coactivator 1-alpha in hippocampal interneurons. Gut microbiota-derived IPA is an important molecule implicated in the pathogenesis of POD, which could potentially be harnessed for POD prevention. (270 words).